McGill-Gothenburg collaboration yields affordable test that could revolutionize the way AD is diagnosed, studied and treated
By Gillian Woodford
A simple blood test that can detect Alzheimer’s disease (AD) has been discovered and validated in a joint effort by a McGill team and researchers in Sweden. Their results are published in the May issue of The Lancet Neurology. An accompanying commentary calls the discovery “transformative.”
Montreal medical specialists and 3D printing company team up to find solutions for critical supply shortages
The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered with a 3D printing company to design and distribute face shields to protect healthcare workers as they treat patients with this life-threatening disease.
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
Since 1957, The Gairdner Foundation has been recognizing the achievements of the world’s top researchers for their contributions to health science. This year, Dr. Guy Rouleau joins an elite group of scientists by receiving the Canada Gairdner Wightman Award.
Study suggests humans have developed complementary neural systems in each hemisphere for auditory stimuli
Speech and music are two fundamentally human activities that are decoded in different brain hemispheres. A new study used a unique approach to reveal why this specialization exists.
McGill researchers are pioneering a new artificial pancreas system that provides life-changing support to people living with type 1 diabetes.
By Ashley Rabinovitch
By Gillian Woodford
A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found.
Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer.
New machine learning study suggest the presence of at least nine gender “expressions”
McGill researchers identify new markers for early detection of cervical cancer
By Ashley Rabinovitch
By Monica Slanik, School of Physical and Occupational Therapy
Open source app helps predict brain tumour malignancy and patient survival
The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A study published today is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
New technique could be used to choose best therapies for patients and measure their effectiveness
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.
McGill researchers’ findings show that may be the case
Humanizing Patient Care
Dr David Hornstein's ICU Diaries Project appeared in La Presse on 22 December. Read more!
Insight into way enzymes work could shape future therapeutic production
Researchers at McGill University’s Faculty of Medicine have made important strides in understanding the functioning of enzymes that play an integral role in the production of antibiotics and other therapeutics. Their findings are published in Science.
Researchers identify path to improve HER2+ breast cancer susceptibility to approved therapies
